Acne is one of the most common skin conditions aesthetic practitioners and dermatologists will face in their clinics. It affects 742 million patients globally, and 95% of 11-30-year-olds in the UK suffer from the condition to some degree.1,2 There are a number of aesthetic treatments available to treat mild-to-moderate acne either temporarily or semi-permanently, but AviClear from Cutera is the first US FDA-cleared aesthetic device to treat mild-to-severe acne, with permanent results.3 According to Cutera, AviClear will offer patients an alternative to prescription medications which can trigger side effects, requiring just three 30-minute sessions to provide a long-term solution to active acne.
One of the leading causes of acne is the sebaceous glands becoming blocked with the oily substance sebum.4 Many energy-based devices can be used to treat mild-to-moderate acne, such as radiofrequency…
